June 2010

New CEO appointed

B&O Medicom, Struer, Denmark, June 1 2010

Henrik Kagenow has resigned from his post as CEO of Bang & Olufsen Medicom a/s 1st June by mutual agreement, and Erik Trock-Jansen has been appointed as the new CEO of Bang & Olufsen Medicom a/s 1st June.

As chairman of the board I would like to take this opportunity to thank Henrik for his great contribution to the company over the years. Henrik started in Bang & Olufsen Technology 12 years ago and helped to establish Medicom as an independent company in 2000. Today we have a strong position in drug delivery devices and a leading position in digital electronic stethoscopes. This is very much Henrik’s accomplishment.

In future we will be even more focused on operating as a consulting and development company within drug delivery device development, while expanding our position as a one stop shop for our customers. Furthermore, we need to have an even stronger focus on the commercialization of our services. This is the background for the management change today.

Erik Trock-Jansen comes to Bang & Olufsen Medicom a/s with more than 20 years of international experience in business development and start-ups in Asia. Among others, Erik has worked for EAC, McKinsey & Co., Novartis, DKSH and later in Denmark with Tytex in Ikast.

In connection with the change I wish to again thank Henrik for his work with Medicom. Henrik will be working with special projects and assignments during a transitional period. At the same time, I would like to welcome Erik.

Peer Nørkjær
Chairman of the board
Bang & Olufsen Medicom a/s

B&O Medicom is a global, Danish company, specialized in the development and manufacturing of user-friendly drug delivery device solutions and services. Inhalation, injection and tablet dispensing are and have been key focus areas for more than 20 years. Medicom employs around 80 employees in locations in Struer and in Copenhagen and more than 80% of the business is exported.

For more information about B&O Medicom: medicomnordic.com